How have KHRN shares performed in 2024?

Khiron Life Sciences' stock was trading at C$0.04 at the start of the year. Since then, KHRN shares have increased by 0.0% and is now trading at C$0.04. View the best growth stocks for 2024 here .

What other stocks do shareholders of Khiron Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Khiron Life Sciences investors own include Aurora Cannabis (ACB) , Cross Timbers Royalty Trust (CRT) , Curaleaf (CURLF) , Walt Disney (DIS) , Energy Transfer (ET) , KushCo (KSHB) , Neptune Wellness Solutions (NEPT) , Organigram (OGI) and VIVO Cannabis (VVCIF) .

How do I buy shares of Khiron Life Sciences?

Shares of KHRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:KHRN

Khiron Life Sciences (KHRN) Stock Price, News & Analysis

→ This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad)

Free KHRN Stock Alerts

C$0.04

0.00 (0.00%)

(As of 05/5/2023)

Compare

Today's Range: C$0.04
▼
C$0.05
50-Day Range: C$0.04
▼
C$0.04
52-Week Range: C$0.04
▼
C$0.21

Volume: 24,000 shs
Average Volume: 256,268 shs
Market Capitalization: C$9.30 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Headlines

Get Khiron Life Sciences alerts:

Ad The Bull Report

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

About Khiron Life Sciences Stock (CVE:KHRN)

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

KHRN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

KHRN Stock News Headlines

December 21, 2023 | msn.com

Focus: Colombia's cannabis industry in crisis over regulatory, political hurdles

November 17, 2023 | benzinga.com

Global Cannabis Co. Trading Lower On Announcing Amended European Business Sale Deal

April 19, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

November 16, 2023 | finance.yahoo.com

Khiron Life Sciences Announces Update to the Proposed Sale of Its European Business

May 24, 2023 | theglobeandmail.com

Closing Bell: Khiron Life Sciences Corp WT up on Friday (KHRN-WT)

May 20, 2023 | theglobeandmail.com

Closing Bell: Khiron Life Sciences Corp down on Monday (KHRN)

May 4, 2023 | theglobeandmail.com

Closing Bell: Khiron Life Sciences Corp WT down on Tuesday (KHRN-WT)

April 26, 2023 | theglobeandmail.com

Closing Bell: Khiron Life Sciences Corp down on Tuesday (KHRN)

April 19, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

April 25, 2023 | msn.com

Cannabis Movers & Shakers: Latest Appointments From Khiron, MariMed, Equilibria & More

April 25, 2023 | finance.yahoo.com

Medical First: Germany Strengthens Reimbursement of Medical Cannabis

April 22, 2023 | theglobeandmail.com

Closing Bell: Khiron Life Sciences Corp WT flat on Friday (KHRN-WT)

April 21, 2023 | theglobeandmail.com

Closing Bell: Khiron Life Sciences Corp up on Thursday (KHRN)

April 21, 2023 | msn.com

Khiron Completes First Phase Of Business Optimization, Reduces Total Direct Labor Headcount By More Than 70% In Its Colombia SAS Subsidiary

April 20, 2023 | theglobeandmail.com

Closing Bell: Khiron Life Sciences Corp WT flat on Tuesday (KHRN-WT)

April 15, 2023 | theglobeandmail.com

Closing Bell: Khiron Life Sciences Corp flat on Friday (KHRN)

April 14, 2023 | theglobeandmail.com

Closing Bell: Khiron Life Sciences Corp down on Wednesday (KHRN)

April 14, 2023 | theglobeandmail.com

Closing Bell: Khiron Life Sciences Corp WT flat on Thursday (KHRN-WT)

April 7, 2023 | theglobeandmail.com

Closing Bell: Khiron Life Sciences Corp WT flat on Wednesday (KHRN-WT)

April 4, 2023 | finance.yahoo.com

Khiron Life Sciences Announces Closing of Marketed Offering Including Full Exercise of Over-Allotment Option

March 27, 2023 | finance.yahoo.com

KHIRON LIFE SCIENCES ANNOUNCES SIZING OF MARKETED OFFERING OF UNITS

March 13, 2023 | finance.yahoo.com

KHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT MARKETED OFFERING

February 11, 2023 | theglobeandmail.com

Khiron Life Sciences: Stocks Overvalued by Analyst Consensus on TSX-V (KHRN)

January 19, 2023 | ca.finance.yahoo.com

Khiron begins dispensation of insurance-covered prescriptions in Colombia

January 19, 2023 | finanznachrichten.de

Khiron Life Sciences Corp.: Khiron begins dispensation of insurance-covered prescriptions in Colombia

January 16, 2023 | benzinga.com

NHS reimburses the cost of cannabis treatment to the first Zerenia™ Clinics UK patient

January 16, 2023 | finanznachrichten.de

Khiron Life Sciences Corp.: NHS reimburses the cost of cannabis treatment to the first Zerenia Clinics UK patient

See More Headlines

Receive KHRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: CVE:KHRN
CUSIP: N/A
CIK: N/A
Web: www.khiron.ca
Phone: 705-527-3564
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($0.17)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-30,660,000.00
Net Margins: -190.00%
Pretax Margin: N/A
Return on Equity: -74.68%
Return on Assets: -20.79%

Debt

Debt-to-Equity Ratio: 9.46
Current Ratio: 2.02
Quick Ratio: 0.72

Sales & Book Value

Annual Sales: C$16.14 million
Price / Sales: 0.58
Cash Flow: C$0.01 per share
Price / Cash Flow: 6.67
Book Value: C$0.12 per share
Price / Book: 0.33

Miscellaneous

Outstanding Shares: 232,410,000
Free Float: N/A
Market Cap: C$9.30 million
Optionable: Not Optionable
Beta: 2.64

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Dr. Alvaro Francisco Torres (Age 45)
Co-Founder, CEO & Director
Comp: $272.95k
Ms. Franziska Katterbach
President of Khiron Europe
Mr. Swapan Kakumanu ACA (Age 54)
ACWA, CGA, Corporate Secretary
Comp: $60k
Mr. Michael John O'Connor MA (Age 57)
Chief Financial Officer
Mr. Manuel Buendia
Vice President of Operations
Mr. Marco Algorta
Country Manager of Uruguay

Key Competitors

View All Competitors

KHRN Stock Analysis - Frequently Asked Questions

How have KHRN shares performed in 2024?: Khiron Life Sciences' stock was trading at C$0.04 at the start of the year. Since then, KHRN shares have increased by 0.0% and is now trading at C$0.04.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Khiron Life Sciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Khiron Life Sciences investors own include Aurora Cannabis (ACB), Cross Timbers Royalty Trust (CRT), Curaleaf (CURLF), Walt Disney (DIS), Energy Transfer (ET), KushCo (KSHB), Neptune Wellness Solutions (NEPT), Organigram (OGI) and VIVO Cannabis (VVCIF).
How do I buy shares of Khiron Life Sciences?: Shares of KHRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:KHRN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial